TGFBI and ovarian cancer: Recent findings have suggested that TGFBI also sensitizes ovarian cancer cells to paclitaxel by inducing microtubule stabilization and that the loss of TGFBI induces drug resistance and mitotic spindle abnormalities in ovarian cancer cells [17].